DGAP-News

RHÖN-KLINIKUM AG: Interim Report for the First Quarter of 2015: financial year begins strongly for RHÖN-KLINIKUM AG - research and quality offensive strengthens our market position in cutting-edge healthcare

DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Quarter
Results/Miscellaneous
RHÖN-KLINIKUM AG: Interim Report for the First Quarter of 2015:
financial year begins strongly for RHÖN-KLINIKUM AG - research and
quality offensive strengthens our market position in cutting-edge
healthcare

07.05.2015 / 07:00

---------------------------------------------------------------------

Corporate News

Interim Report for the First Quarter of 2015: financial year begins
strongly for RHÖN-KLINIKUM AG - research and quality offensive strengthens
our market position in cutting-edge healthcare

- 191,730 patients treated

- Revenues stand at EUR 276.1 million

- EBITDA amounts to EUR 49.7 million

- Outlook for 2015: Revenues between EUR 1.08 billion and EUR 1.12
billion,EBITDA between EUR 145 million and EUR 155 million

Bad Neustadt/Saale, 7th May 2015

In the first quarter of the current financial year almost 200,000 (191,730
to be precise) patients were treated in the hospitals of RHÖN-KLINIKUM AG.
Revenues amounted to EUR 276.1 million for the period from January to March
with earnings before interest, taxes, depreciation and amortisation
(EBITDA) standing at EUR 49.7 million. These financial figures are not
directly comparable with those of previous years due to the sale of a total
of 43 facilities which was completed in the last financial year.

Annual General Meeting on 10th June 2015

The Board of Management and Supervisory Board shall propose to this year's
ordinary Annual General Meeting the distribution of the net consolidated
profit in the form of a dividend in the amount of EUR 0.80 per non-par
share to the shareholders. The Company also wishes the shareholders to be
able to participate extensively in subsequent years in the future success
of the Company by means of dividend payout ratios which are clearly above
60 % of the group profit. A precondition is that growth increasing the
value of the Company will not be realised by acquisitions, for example.

We are currently planning to carry out another share repurchase scheme
after the Annual General Meeting through a public purchase offer with a
volume of approx. 10 % of the current share capital. The corresponding
authorisation was already granted by the Annual General Meeting in 2014. A
final decision by the Board of Management and Supervisory Board on the